{"id":46431,"date":"2024-02-26T03:12:52","date_gmt":"2024-02-26T03:12:52","guid":{"rendered":"https:\/?p=46431"},"modified":"2024-02-26T03:12:52","modified_gmt":"2024-02-26T03:12:52","slug":"analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/","title":{"rendered":"Analysts Rate Maravai Lifesciences with a Consensus &#8220;Strong Buy&#8221; rating"},"content":{"rendered":"<h3><strong>RBC Raises Target Price for Maravai Lifesciences\u00a0<\/strong><\/h3>\n<p><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/MRVI\/analyst-rating\">Maravai Lifesciences Holdings Inc, a<\/a> leading life sciences company, has received an optimistic outlook from RBC Capital Markets, which raised its 12-month target price for the company to $14 from $12 while maintaining an Outperform rating. This upward revision reflects RBC&#8217;s confidence in Maravai&#8217;s growth prospects and market performance moving forward.<\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/MRVI\" target=\"_blank\" rel=\"noopener\">MRVI Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"MRVI\" data-theme=\"wt_bg_light\" data-uid=\"154522925965dc0160354af65dc0160354b1\" data-width=\"900\" >\n\t\t<\/script><\/p>\n<\/div>\n<p>According to forecasts from four analysts, the average target price for Maravai Lifesciences Holdings Inc over the next 12 months stands at USD 10.00. This average analyst target price indicates a positive sentiment among analysts, suggesting potential upside for investors considering Maravai&#8217;s stock.<\/p>\n<p>Furthermore, Maravai Lifesciences Holdings Inc&#8217;s average analyst rating is categorized as &#8220;Strong Buy,&#8221; emphasizing the consensus among analysts regarding the company&#8217;s investment attractiveness. Analysts&#8217; bullish sentiment is driven by factors such as Maravai&#8217;s innovative product portfolio, strategic initiatives, and promising growth trajectory within the life sciences industry.<\/p>\n<p>Stock Target Advisor&#8217;s own analysis of Maravai Lifesciences Holdings Inc aligns with this positive outlook, characterizing the company&#8217;s stock as &#8220;Slightly Bullish.&#8221; This assessment is based on a combination of ten positive signals and six negative signals, indicating a favorable stance towards Maravai&#8217;s stock performance.<\/p>\n<p>At the latest closing, Maravai Lifesciences Holdings Inc&#8217;s stock price was recorded at USD 8.36. This price reflects a notable increase of +57.44% over the past week and a significant surge of +36.60% over the past month. However, despite these recent gains, Maravai&#8217;s stock price has experienced a decline of -41.78% over the last year, highlighting the volatility and fluctuations within the market.<\/p>\n<p>The positive sentiment from RBC Capital Markets, coupled with the consensus among analysts and Stock Target Advisor&#8217;s analysis, underscores Maravai Lifesciences Holdings Inc&#8217;s potential for growth and value appreciation. Investors may view RBC&#8217;s target price revision as a vote of confidence in Maravai&#8217;s business fundamentals and future performance.<\/p>\n<p>As investors evaluate their investment options, it&#8217;s essential to conduct thorough research and consider various factors, including company fundamentals, industry dynamics, and market trends. By staying informed and vigilant, investors can make well-informed decisions that align with their investment objectives and risk tolerance, maximizing their potential for long-term success in the market.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>RBC Raises Target Price for Maravai Lifesciences\u00a0 Maravai Lifesciences Holdings Inc, a leading life sciences company, has received an optimistic outlook from RBC Capital Markets,&#8230;<\/p>\n","protected":false},"author":3,"featured_media":46433,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-46431","post","type-post","status-publish","format-image","has-post-thumbnail","hentry","category-blog","post_format-post-format-image"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Analysts Rate Maravai Lifesciences with a Consensus &quot;Strong Buy&quot; rating | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Analysts Rate Maravai Lifesciences with a Consensus &quot;Strong Buy&quot; rating\" \/>\n<meta property=\"og:description\" content=\"RBC Raises Target Price for Maravai Lifesciences\u00a0 Maravai Lifesciences Holdings Inc, a leading life sciences company, has received an optimistic outlook from RBC Capital Markets,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-26T03:12:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/02\/Marval.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"Analysts Rate Maravai Lifesciences with a Consensus &#8220;Strong Buy&#8221; rating\",\"datePublished\":\"2024-02-26T03:12:52+00:00\",\"dateModified\":\"2024-02-26T03:12:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/\"},\"wordCount\":365,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/\",\"name\":\"Analysts Rate Maravai Lifesciences with a Consensus \\\"Strong Buy\\\" rating | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2024-02-26T03:12:52+00:00\",\"dateModified\":\"2024-02-26T03:12:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Analysts Rate Maravai Lifesciences with a Consensus &#8220;Strong Buy&#8221; rating\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Analysts Rate Maravai Lifesciences with a Consensus \"Strong Buy\" rating | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/","og_locale":"en_US","og_type":"article","og_title":"Analysts Rate Maravai Lifesciences with a Consensus \"Strong Buy\" rating","og_description":"RBC Raises Target Price for Maravai Lifesciences\u00a0 Maravai Lifesciences Holdings Inc, a leading life sciences company, has received an optimistic outlook from RBC Capital Markets,...","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2024-02-26T03:12:52+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/02\/Marval.jpg","type":"image\/jpeg"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"Analysts Rate Maravai Lifesciences with a Consensus &#8220;Strong Buy&#8221; rating","datePublished":"2024-02-26T03:12:52+00:00","dateModified":"2024-02-26T03:12:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/"},"wordCount":365,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/","name":"Analysts Rate Maravai Lifesciences with a Consensus \"Strong Buy\" rating | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2024-02-26T03:12:52+00:00","dateModified":"2024-02-26T03:12:52+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analysts-rate-maravai-lifesciences-with-a-consensus-strong-buy-rating\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Analysts Rate Maravai Lifesciences with a Consensus &#8220;Strong Buy&#8221; rating"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/46431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=46431"}],"version-history":[{"count":1,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/46431\/revisions"}],"predecessor-version":[{"id":46434,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/46431\/revisions\/46434"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/46433"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=46431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=46431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=46431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}